Minor histocompatibility antigens – big in tumour therapy
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 25 (2) , 56-60
- https://doi.org/10.1016/j.it.2003.12.002
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humansBlood, 2003
- Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility AntigensThe Journal of Experimental Medicine, 2003
- Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignanciesThe Hematology Journal, 2003
- The Hematopoietic System–specific Minor Histocompatibility Antigen HA-1 Shows Aberrant Expression in Epithelial Cancer CellsThe Journal of Experimental Medicine, 2002
- Advances in Rho-dependent actin regulation and oncogenic transformationCurrent Opinion in Genetics & Development, 2002
- Embryonic genes in cancerAnnals of Oncology, 2000
- Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility AntigenScience, 1995
- Y-antigen killing by T cells of women is restricted by HLANature, 1977
- ALLOIMMUNITY TO HUMAN H-YThe Lancet, 1976
- Strong and Weak Histocompatibility Gene Differences in Mice and Their Role in the Rejection of Homografts of Tumors and SkinAnnals of Surgery, 1956